ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 811

Antibody Response to Periodontogenic Bacterium Aggregatibacter Actinomycetemcomitans and Lupus

Harini Bagavant1, Nina Wolska2, Stan Kamp3, Joel M. Guthridge1, Judith A. James4, Joan T. Merrill3 and Umesh S Deshmukh1, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Periodontitis and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Periodontitis is an inflammation of the soft and hard tissues supporting the tooth.  Aggregatibacter actinomycetemcomitans (Aa), a gram negative bacterium, is strongly associated with the aggressive form of periodontitis, particularly in young females.  Aa and its toxins induce apoptotic cell death in immune cells and hence can modulate the mucosal immune responses.  In this study, we tested the hypothesis that an infection with Aa is associated with increased autoimmunity in lupus patients. 

Methods: Circulating antibodies to Aa are indicative of an ongoing or prior infection with the organism. Thus, serum antibodies to Aa in lupus patients and controls from the Oklahoma cohort of rheumatic disease were measured by ELISA. The lupus patients with anti-Aa antibody units higher than mean+2SD of controls were classified as positive for anti-Aa. To determine the association between anti-Aa and autoantibodies to lupus-associated antigens (dsDNA, Ro/SSA, La/SSB, Sm, RNP, Ribosomal P, and Jo-1), contingency tables were constructed and statistical significance calculated using Fisher’s exact test.  Neutrophil extracellular traps (NETs) are suspected to be the source of autoantigens in lupus. Thus, the ability of Aa to induce NETosis was tested by using bone marrow derived neutrophils from lupus-prone mice. NET formation was evaluated by staining for DNA and citrullinated histones.

Results: A significant number of lupus patients (128/534, 23.97%) were positive for anti-Aa antibodies, compared to controls (1/21; 4.76%; p=0.037). Stratification of lupus patients by race showed that African American patients had significantly higher anti-Aa antibody titers as compared to patients of Caucasian origin. However, regardless of the race, anti-Aa antibody positivity was significantly associated with higher anti-dsDNA (p=0.002).  No association was observed with other autoantibody specificities. Incubation of neutrophils with Aa readily induced NETosis.

Conclusion: This study shows that an ongoing or prior infection with the periodontogenic bacterium Aa is associated with increased anti-dsDNA in lupus patients. Our data suggests the possibility that Aa induced NETosis might be involved in the amplification of anti-dsDNA response in lupus patients. Considering that the incidence of periodontitis is higher in African Americans, our study provides a strong rationale to investigate the possible link between periodontal disease and lupus in African American patients


Disclosure: H. Bagavant, None; N. Wolska, None; S. Kamp, None; J. M. Guthridge, None; J. A. James, None; J. T. Merrill, None; U. S. Deshmukh, None.

To cite this abstract in AMA style:

Bagavant H, Wolska N, Kamp S, Guthridge JM, James JA, Merrill JT, Deshmukh US. Antibody Response to Periodontogenic Bacterium Aggregatibacter Actinomycetemcomitans and Lupus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/antibody-response-to-periodontogenic-bacterium-aggregatibacter-actinomycetemcomitans-and-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/antibody-response-to-periodontogenic-bacterium-aggregatibacter-actinomycetemcomitans-and-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology